COMMUNIQUÉS West-GlobeNewswire
-
IBA – ACQUISITION D’ACTIONS PROPRES
05/05/2026 -
VALNEVA: Declaration of shares and voting rights - Status as of April 30, 2026 taking into account interim information as at May 5, 2026
05/05/2026 -
VALNEVA : Déclaration d’actions et de droits de vote - Statut au 30 avril 2026 tenant compte d’informations intermédiaires au 5 mai 2026
05/05/2026 -
IBA – TRANSPARENCY NOTIFICATION
05/05/2026 -
IBA SA – NOTIFICATION TRANSPARENCE
05/05/2026 -
Valneva to Report First Quarter 2026 Consolidated Financial Results on May 13, 2026
05/05/2026 -
Valneva publiera ses résultats financiers consolidés du premier semestre le 13 mai 2026
05/05/2026 -
NTG Nordic Transport Group A/S invites to Capital Markets Day on November 18, 2026
05/05/2026 -
CORRECTION: GenEmbryomics and Genomic Prediction Launch XGEN PGT-X™
05/05/2026 -
NTG Nordic Transport Group publishes interim report for Q1 2026
05/05/2026 -
Canadian Soccer Standout Cloey Uddenberg and Team Physician Dr. Kevin Asem Join Lung Health Foundation’s National Push to Keep Kids with Asthma in the Game
05/05/2026 -
Atos and CNA strengthen long-term strategic partnership through new multi-year infrastructure services agreement
05/05/2026 -
Lighthouse Autism Center Opening New Autism Therapy Center in Council Bluffs, Iowa
05/05/2026 -
Bayridge Counselling Centres and No Fear Counselling Corp Merge Under Ch’íyáqtel Wellness to Form Canada’s Largest First Nation’s Owned Mental Health Network
05/05/2026 -
Lighthouse Autism Center Opening New Autism Therapy Center in Mount Pleasant, Iowa
05/05/2026 -
FEATOL Introduces Back Brace Support Belt for Everyday Lower Back Support
05/05/2026 -
MindBio Develops Cross-Language AI Speech Analytics Capability for Intoxication Detection Patent applications filed in 15 world firsts using Voice and AI
05/05/2026 -
Alpha Tau Announces Upcoming Podium Presentation at the AHNS 12th International Conference on Head and Neck Cancer Showcasing Study Results of Alpha DaRT® Head and Neck Cancer Combination with Pembrolizumab
05/05/2026 -
SK pharmteco Achieves SBTi Validation for 2040 Net-Zero Science-Based Targets
05/05/2026
Pages